DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ rallied 2.15% to $9.52 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 2.03% to 19,733.59 and the Dow Jones Industrial Average rising 0.31% to 44,850.35.
This was the stock's second consecutive day of gains.
Novavax Inc. closed 60.10% below its 52-week high of $23.86, which the company reached on June 6th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.64% to $150.38, Pfizer Inc. $(PFE)$ fell 0.41% to $26.75, and Merck & Co. Inc. $(MRK)$ fell 0.50% to $97.45.
Trading volume (3.4 M) remained 988,292 below its 50-day average volume of 4.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 28, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 28, 2025 17:31 ET (22:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。